Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- NEW

- 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- is a chemical compound that is an intermediate for ticagrelor synthesis.

- Its molecular formula is C17H22ClN5O4S and its molecular weight is 443.91 g/mol.

- Its appearance is a white to off-white powder.

- Its melting point is about 180°C.

- Ticagrelor is a novel, selective, oral antiplatelet drug that reversibly binds to the P2Y12 receptor on vascular smooth muscle cells (VSMCs) and inhibits ADP-induced platelet aggregation. It has a rapid onset of action and can effectively improve the symptoms of acute coronary syndrome patients .

- Ticagrelor has been approved by the US FDA and the EU for the prevention of atherothrombotic events in adult patients with acute coronary syndrome .

Email:pharmchem1@ichemie.com    

Tel & Whatsapp: +86-18771921569